GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » YoY EBITDA Growth

Accelerated Pharma (Accelerated Pharma) YoY EBITDA Growth : 75.81% (As of Mar. 2017)


View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Accelerated Pharma's YoY EBITDA Growth for the quarter that ended in Mar. 2017 was 75.81%.

Accelerated Pharma's EBITDA per Share for the three months ended in Mar. 2017 was $-0.05.

Accelerated Pharma YoY EBITDA Growth Historical Data

The historical data trend for Accelerated Pharma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma YoY EBITDA Growth Chart

Accelerated Pharma Annual Data
Trend Dec14 Dec15 Dec16
YoY EBITDA Growth
- - 12.48

Accelerated Pharma Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
YoY EBITDA Growth Get a 7-Day Free Trial - - - 82.44 75.81

Accelerated Pharma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Accelerated Pharma's YoY EBITDA Growth for the fiscal year that ended in Dec. 2016 is calculated as:

YoY EBITDA Growth (A: Dec. 2016 )
=(EBITDA per Share (A: Dec. 2016 )-EBITDA per Share (A: Dec. 2015 ))/ | EBITDA per Share (A: Dec. 2015 ) |
=(-0.449--0.513)/ | -0.513 |
=12.48 %

Accelerated Pharma's YoY EBITDA Growth for the quarter that ended in Mar. 2017 is calculated as:

YoY EBITDA Growth (Q: Mar. 2017 )
=(EBITDA per Share (Q: Mar. 2017 )-EBITDA per Share (Q: Mar. 2016 )) / | EBITDA per Share (Q: Mar. 2016 )) |
=(-0.052--0.215)/ | -0.215 |
=75.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accelerated Pharma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » YoY EBITDA Growth
Comparable Companies
NUVPF ADMD RSPI YBAO ULUR NRXCF ACUR LBLTF PUFXF BKIT RLMD IGC MYOS CBICF SBFM PVCT AQSZF PTLF AOLS APRI
Traded in Other Exchanges
N/A
Address
Website
Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines